NCT06091826View on ClinicalTrials.gov

Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO)

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

September 15, 2023

Study Completion Date

September 30, 2023

Conditions
Smoking CessationNicotine Dependence
Interventions
DRUG

NFL-101

Subcutaneous injections

DRUG

Placebo

Subcutaneous injections

Trial Locations (1)

38610

Eurofins Optimed, Gières

Sponsors
All Listed Sponsors
lead

NFL Biosciences SAS

INDUSTRY

NCT06091826 - Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO) | Biotech Hunter | Biotech Hunter